Megumi Numata

Title: Megumi Numata: Innovator in Antibody Formulations

Introduction

Megumi Numata is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of biopharmaceuticals, particularly in the development of antibody formulations. With a total of 3 patents to her name, her work focuses on innovative solutions for stabilizing and administering antibodies.

Latest Patents

Her latest patents include formulations containing anti-IL-31RA antibodies. One of her notable inventions involves lyophilized formulations that contain an IL-31 antagonist as an active ingredient, along with arginine and/or a salt thereof and sucrose and/or trehalose. Additionally, she has developed solution formulations that also incorporate these components. Her work emphasizes methods for stabilizing antibodies, suppressing aggregation, and reducing charge heterogeneity in antibody formulations.

Career Highlights

Megumi Numata is currently employed at Chugai Seiyaku Kabushiki Kaisha, where she continues to advance her research in antibody formulations. Her innovative approaches have positioned her as a key figure in her field, contributing to the development of effective therapeutic solutions.

Collaborations

Throughout her career, she has collaborated with notable colleagues, including Daisuke Kameoka and Toru Yoshizawa. These partnerships have further enhanced her research and development efforts in biopharmaceuticals.

Conclusion

Megumi Numata's work in antibody formulations showcases her dedication to innovation in the biopharmaceutical industry. Her contributions are paving the way for advancements in therapeutic applications, making her a significant figure in her field.